Perzea Launch by Hetero Healthcare and Enzene Supports India’s Vision of Accessible Cancer Care

“Hetero Healthcare is proud to support the nation’s healthcare goals,” said Mr. M. Srinivas Reddy, Managing Director. “Perzea represents our responsibility to provide Indian patients with world-class therapies at a fraction of global costs.”

Strengthening Oncology Access in India
This launch also reflects India’s growing role as a hub for biosimilar development. By collaborating with Enzene Biosciences, Hetero Healthcare demonstrates how partnerships can combine science, scale, and affordability to improve patient outcomes.

About Hetero Healthcare
Hetero Healthcare Limited has been a leader in oncology, antiretrovirals, and critical care therapies. Its mission to deliver affordable healthcare solutions across India continues to make a profound impact on millions of lives. More: www.heterohealthcare.com

About Enzene Biosciences
Enzene is advancing biologics manufacturing through its EnzeneX™ technology, aiming to reduce monoclonal antibody production costs significantly. Its focus on innovation and efficiency supports global access to critical therapies. More: www.enzene.com

Disclaimer: This article is for general information purposes only and should not be construed as professional medical advice. Always consult your doctor before taking any step.

Disclaimer: The content of this post has been automatically published from an agency feed without any changes to the original text and has not been reviewed by our company's editor. Our editorial team or company does not take responsibility for any errors or inaccuracies.